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Abstract
Background
Out of pocket payment (OOPP), is the major health financing mechanism in South Asia
region. With the rising burden of non-communicable diseases (NCDs), the region is facing a
high financial burden. However, the extent and nature of economic impact caused by treat-
ment and management of NCDs at the household level is yet unknown.
Method
We conducted a systematic review using Medline and Embase databases. Only peer-
reviewed quantitative studies published between January 2000 to December 2016 assess-
ing OOPP or catastrophic health expenditure or impoverishment or financial coping strategy
due to at least one of the four major NCDs—cardiovascular diseases(CVDs), diabetes, can-
cer, chronic respiratory disease in South Asia region was included in the review. The review
is registered in PROSPERO no: CRD42017059345.
Results
A total of 21 studies (of 2693 records identified) met the inclusion criteria. The economic
impact was most frequently studied in CVDs and in terms of OOPP. The studies collectively
indicated high OOPP, higher likelihood of catastrophic expenditure and impoverishment for
inpatient care for these major NCDs which was visible in all income levels. Borrowing and
selling off assets were the most common forms of coping strategies adopted and varied
inconsistently between urban and rural households. The true extent of the economic impact,
however, remains difficult to determine due to methodological heterogeneity regarding out-
comes reported and measures employed for calculation of OOPP, catastrophic expenditure,
and impoverishment across these four major NCDs and between nations.
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Conclusion
The economic impact due to treatment and management of CVDs, diabetes, cancer and
chronic respiratory diseases among households in South Asia seems dire. Given the lack of
sufficient evidence the review stresses the need for further research in the region to develop
evidence-informed nationally tailored prepayment mechanisms covering NCDs to reduce
economic vulnerability and standardization of tools measuring the economic impact for gen-
erating comparable estimates.
Introduction
Globally, cardiovascular diseases (CVDs), cancers, chronic respiratory diseases (chronic
obstructive pulmonary disease and asthma) and diabetes are leading non-communicable dis-
eases (NCDs) contributing 81% of all NCDs related mortality [1]. NCDs also accounts for 58%
of the Disability Adjusted Life Years (DALYs) [1]. With rapid urbanization, sedentary lifestyle
[2], increased consumption of unhealthy diets, high alcohol use, and high blood pressure the
burden of NCDs have escalated throughout the world in between 1990 and 2010 so as in South
Asia [3, 4]. The South Asian countries namely Afghanistan, Bangladesh, Bhutan, Maldives,
Nepal, India, Pakistan and Sri Lanka, which are mostly low and middle-income countries with
regional Gross Domestic Product (GDP) per capita 1639.7 United States Dollar (USD) and
home to a quarter of world population [5]. The region currently bears a high burden of NCDs,
and related death is expected to increase by 20% in the World Health Organization (WHO)-
South-East Asia Region [6]. Studies suggest that the manifestation of CVDs and onset of diabe-
tes is much earlier among South Asians than other ethnicities due to adverse metabolic factors
requiring longer-term medication [7].
The growing incidence of NCDs threatens the already weakened health system in South
Asia [7, 8]. In the absence of adequate policy direction, diagnostic capacity and effective orga-
nizational measures; addressing these emerging NCDs will have a far-reaching impact on
health care, both at the individual and institutional level in South Asia. People will be required
to pay for expensive treatments and medications out of pocket as most of the countries in the
region do not have a functional population-wide insurance system. Financing for health
depends heavily on out of pocket payment (OOPP) [9] in the region, which is a derogatory
form of health financing. OOPP increases households cost associated with healthcare and
forces households to unprecedented financial catastrophe and impoverishment [10]. WHO
defines catastrophic health expenditure as the health expenditure greater than or equal to 40%
of a household’s effective income remaining after basic subsistence needs have been met
(capacity to pay). If catastrophic expenditure pushes a household below this income threshold
the poverty line it is known as impoverishment [11]. In this article, the term economic impact
collectively refers to the impact caused by OOPP, catastrophic health expenditure, impoverish-
ment or any other indirect costs and financial burden incurred due to management and treat-
ment of CVDs, diabetes, chronic respiratory diseases and cancers. Individuals are not very
price sensitive when it comes to treatment and management of disease like NCDs which trig-
gers premature death or disabilities if not treated timely [12]. Hence, households despite their
incapability to pay for the health-care services undergo catastrophic payment or adopt differ-
ent coping behaviors to meet the financial need for hospitalization and health care costs [13].
Whereas, this economic constraint may also lead to the number of untreated cases eventually
increasing the burden of NCDs.
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The quarter of world population (where 15.1% of the population live under 1.90 USD per day)
[5] living in this region are on the verge of slipping into a vicious cycle of poverty and impoverish-
ment while seeking for healthcare services specially for NCDs. This compromises the attainment
of the global goal of Universal Health Coverage which is target 8 of goal number 3 of Sustainable
Development Goals (SDG) [14]. This goal calls for grand convergence to provide health services
relative to need and ensuring financial protection so that health care is within reach of all the pop-
ulation. It also further challenges the attainment of the global action plan for prevention and con-
trol of NCDs 2013–2020 which deals with relative reduction of premature NCDs deaths by 25%
by 2025 and reducing the contribution of NCDs in financial impoverishment, by identifying the
NCDs which needs the urgent intervention at the country level [15].
The current literatures on the discourse of assessing financial burden of NCDs in the low
and middle-income countries by Kankeu et al. [16] and Gupta et al.[17] emphasize the need
for prioritizing robust research on estimating costs incurred and impoverishment effect due to
NCDs. It is important to carry out new research to produce evident knowledge in the resource
constraint settings. The need for further research in low and middle-income countries was
also concluded by Jaspers et al. in a systematic review assessing global impact of NCDs and
impoverishment which included eight studies assessing the economic impact of NCDs from
India and two from Pakistan both being South Asian countries [18]. A review of literature by
Saksena et al. discussed the impact of out of pocket payments for non-communicable diseases
in developing countries which also included some studies from India suggested that household
share a substantial proportion of income for NCDs treatment specially hospitalization related
expenditures [19]. However, a comprehensive assessment of the economic impact caused by
specific NCDs exclusively in South Asia region is still missing so far. Hence, given the gap in
the literature, and to update on existing evidence of economic impact by NCDs the current
study will systematically review the existing evidence on the OOPP, catastrophic and impover-
ishment effect of NCDs along with individual and households coping strategies to these finan-
cial constraints in South Asia.
Methods
In order to conduct a systematic review assessing the economic impact of NCDs and impover-
ishment among households in South Asia region, the Preferred Reporting Items for Systematic
Reviews and Meta-analyses statement was used as a reporting guideline for this review. The
PROSPERO registration number for the review is CRD42017059345.
Search strategy
We systematically searched two electronic databases accessed through Ovid: Medline and
EMBASE by using database tailored search strategy. The search strategy was adapted from the
similar systematic review conducted by Jaspers et. al.[18] and was based on PECO (Population,
Exposure Comparison, and Outcome) framework covering the objectives of this review and
appropriate Subject Headings was used and was searched in titles, abstracts, topics, and key-
words depending on the database. The latest search was conducted on 17th February 2017.
Additionally, snowballing technique was applied for the manual search of studies from the list
of references and citations of retrieved articles to identify studies not found in the database
search. The complete search strategy is available as supporting document (S1 Table).
Inclusion criteria
Quantitative studies conducted in at least one of the following countries: Nepal, India, Paki-
stan, Sri Lanka, Bhutan, Bangladesh, Maldives among any gender (male or female) in any age
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group including at least one of the four major NCDs: CVDs, type II diabetes, chronic respira-
tory diseases (chronic obstructive pulmonary disease and asthma) and cancers examining at
least one of the measures of economic consequences caused by NCDs at households were con-
sidered in the review. In this systematic review, we only included peer-reviewed English
research articles published between January 2000 to December 2016.
Given the existence of different types of cancers and our limited resources, the detailed
search strategy in the review majorly focused on cancers with leading DALYs rate among
South Asian male (Lung cancer and Oral Cancer) and female (Breast cancer and Cervical can-
cer) [20]. However, studies assessing the economic impact of these specific cancer or cancers/
neoplasm in general were both included in the review. The economic measures included in the
review were direct costs, indirect costs, expenditure on medicine, transport, out of pocket
expenditure, financial hardship, catastrophic health expenditure, impoverishment, individual
or household cost, poverty line, or coping strategy for NCDs related financial burden.
Exclusion criteria
Studies though satisfying the inclusion criteria but with an inadequate assessment of measures
of outcome, and or of unsatisfactory quality and unfeasible for data extraction were not con-
sidered for the review. Studies from Afghanistan was not considered for the review as it
became the member of South Asia only since 2008.
Study selection
Studies were initially identified based on title and abstracts, and when abstracts were not rele-
vant or did not provide sufficient information, the full-text articles were retrieved and screened
against inclusion and exclusion criteria by first and second author independently. Any dis-
agreement between two reviewers was resolved through consensus and consultation of the
third reviewer.
Data extraction from selected articles
All the references form both the databases were exported to EndNote X7.7.1, and duplicate
studies were removed. Three different data collection forms were made to collect relevant
information from the included articles. The first form included information about the charac-
teristics of studies. The second data extraction form was used for category wise assessing qual-
ity of the study based on the Newcastle–Ottawa Quality Assessment Scale and final quality
score for each study was assigned [18]. The third data extraction form contained the details
about the assessment of the outcome of interest.
Local currencies were converted to US dollars (USD) to enhance comparability between the
eligible studies. We used country specific Purchasing Power Parity conversion rate provided
by World Bank data [21]. The conversion rate of the publication year of the study was used.
Furthermore, all USD were converted to dollars of 2016 using the consumer price index con-
version factors [22].
Risk of bias analysis
Newcastle–Ottawa Quality Assessment Scale (NOS) adapted for the cross-sectional and
descriptive study was used in the review [23]. The NOS scale assesses the quality of the articles
in three domains of selection, comparability, and exposure and is based on ‘star system.’ The
selection and exposure category include four and three items respectively and can be provided
one star each while comparability with one item can be provided two stars. Hence the NOS
Economic impact of NCDs in South Asia
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scale can have maximum nine stars for the highest quality. A score was tallied by adding up
the stars. A study was categorized as being of low risk of bias or highest quality if a total of 8 to
9 stars were allocated, medium risk of bias if 6 to 7 stars were allocated and of high risk or poor
quality if the total score awarded was� 5 stars.
Data analysis and synthesis
Disease-specific data extracted were synthesized in groups and inferences were made. Given
the heterogeneity regarding methods and outcomes addressed, the results were not combined
across studies, and no summary measures were calculated.
Result
From 2,693 references initially screened 22 studies met the inclusion criteria and was included
in the review as shown in Fig 1
Records identiied through
(n=2684)
Fig 1. PRISMA flow-chart for systematic review of studies.
https://doi.org/10.1371/journal.pone.0205745.g001
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Characteristics of the study reviewed
Table 1 shows characteristics of 21 studies included in the review out of which 14 studies were
solely based in India. There were no studies identified from Maldives and Bhutan regarding
Table 1. Characteristics of the studies.
Study
Design
Location Period of
Surveillance
Sampling Number in analysis Gender Age Reported NCD Source,
Publication year
Cohort India Apr 2009-Oct
2011
Purposive 189 ind Both 18 yrs
and
above
Stroke Kwatra et al, 2013
[36]
Mar 2013-Jul
2014
Purposive 644 ind Both 0 to 18 Congenital Heart Disease Raj et al, 2015
[37]
Jun
2011-May2012
Purposive 1635 ind Both 18 yrs
and
above
Acute Coronary events Jan et al, 2016
[35]
Cross-
sectional
India 1995–96 and
2004
Random 200000 hld NA NA Diabetes, Heart Disease,
Cancer, Bronchial Asthma
Engelgau et al.,
2012[25]
2004 Random 74 000 hld NA All ages Cardiovascular disease Karan et al, 2014
[28]
Jun-Sep 2008 Random 210 ind Both 25–70 yrs Acute Coronary syndrome Davidanam et al,
2012[42]
2008–2009 Random 500 ind Both 25–70 yrs Cardiovascular disease Huffman et al,
2011[44]
Jan and Jun2004 Random Diabetes: 438, CVD:
2129 ind
Both NA Diabetes, Cardiovascular
disease
Roa et al, 2011
[38]
NR Purposive 50 ind Both 20–50 yrs Diabetes Grover et al, 2005
[46]
NR Purposive 596 ind Both NA Diabetes Shobhana et al,
2000 [45]
2004 Random 73000 hld Both NA Cancer, Cardiovascular
disease, Diabetes
Joe et al, 2015
[33]
2004 Random 74000 hld NA All ages Cancer Mahal et al,2013
[29]
NA Random 199 ind Both NA Stroke Das et al, 2010
[39]
Mar–May 2011 Random 508 ind Both NA Cancer Nair et al, 2013
[48]
Bangladesh 2012–2013 Random 476 ind Both � 20 yrs COPD Uddin et.al,2014
[60]
Feb-Apr 2010 Purposive 166 ind Both 18+ yrs Diabetes Joshi et. al, 2012
[40]
2009 Purposive 3941 hld NA NA Diabetes, Heart Disease,
Cancer, Asthma
Hamid et al, 2014
[26]
Aug-Nov 2011 Random 1593 hld NA NA Heart Disease, Asthma Rahman et al,
2013 [30]
Pakistan 2009–2010 Purposive 67 ind Female NA Breast Cancer Zaidi et al, 2012
[41]
Jul to Sep 2006 Random 345 ind Both 20–60 yrs Diabetes Khowaja et al,
2007 [47]
Nepal Nov 2011- Jan
2012
Random 1997 hld NA NA Diabetes, Asthma, Heart
Disease
Saito et. al, 2014
[31]
Nepal, Srilanka,
Bangladesh, India
2002–2003 Random Ban:5942, Ind:10692,
Nep:882, SriL:6805 hld
NA 18+ yrs Angina Alam et al, 2014
[24]
Ind: individuals, hld: households, yrs: Years, NA: Not Available
https://doi.org/10.1371/journal.pone.0205745.t001
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economic impact, related impoverishment and coping strategy due to NCDs. Studies varied
from 50 to 200,000 observations. Fifteen studies included individuals as sample unit while
eight studies used household as a unit of analysis and all these studies had sample size >1500
[24–31] [24, 25, 29–34].
Majority of the studies were cross-sectional in nature. Only three studies followed up to six
months after discharge of patients and collected information on economic impact [35–37].
Fifteen studies used random sampling while 9 studies were based on purposive sampling
for identifying the respondents. The purposive sampling was usually done in purposively iden-
tified hospitals or health care center setting among patients visiting health centers or parents/
closet patient party of either hospitalized patients or those who survived hospitalization/sur-
gery except for one where purposive program area was first selected and household survey was
done.
For assessment of NCDs, majority of the studies identified CVDs, diabetes, chronic respira-
tory diseases and cancers based on clinically confirmed/diagnosed record, inpatient/outpatient
cases, hospitalization record, or those who survived hospitalization/surgery. Five studies in the
review identified NCDs based on self-reporting of symptoms or ailments and cross-matching
with the ICD-9 [25] or with categorization of disease based on symptoms reported by previous
studies or WHO classification [26, 30, 38]. While one study self-reported symptoms were first
cross-matched with pre-determined stroke definition and these positive cases were then con-
firmed neurologist [39]. Likewise, two studies used both clinically confirmed cases wherever
information on clinical diagnosis was available if not self-reported symptoms cross matched
with NCD pre-determined categorization was used [24, 31] while one study was entirely based
on self-reporting of the conditions from respondents [40].
In all the studies included in the review, the measure of outcome, i.e., economic impact of
NCD was based on self-reported information on household expenditure or cost or financial
burden at the household or individual level. Two studies applied Propensity Score matching to
assess the economic burden of NCD by comparing the means between the NCD affected
households and matched control household using a t-test [24, 34]. Except one, all other NCDs
were studied the among adult population 18 years and above. CVD was the most frequently
reported NCDs in the studies. Overall, among the 21 studies included in the review, CVD was
most commonly studied NCD (14 studies) followed by diabetes (9 studies), cancer (6 studies)
and lastly chronic respiratory disease (5 studies). Except one study mentioning breast cancer,
no other cancer articles included in the review have specified on the type of cancer assessed in
the study and its economic impact on household [41].
Majority of the studies (12 studies) were of poor quality with scoring� 5 stars, 7 were of
moderate quality and only 3 studies were of high quality [24, 28, 29]. The median quality score
was 5 out of 9 (minimum 1, maximum 8) with an interquartile range of 3. (S2 Table)
Measurement of economic impact
The measurement of economic impact caused by NCDs was heterogeneous. The most com-
mon reported economic impact was OOPP followed by catastrophic health expenditure while
very few studies dealt with impoverishment, financial hardship, and coping strategy.
OOPP and financial burden
The common measure of OOPP was expenditure for per hospital stay or inpatient care or hos-
pitalization cost per household member [24, 25, 34, 35, 38] while cost subdivided in terms of
indirect cost, direct cost, non-medical cost or was calculated altogether [42, 43]. OOPP as the
Economic impact of NCDs in South Asia
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proportion of total household spending [34, 38] or perceived financial hardship by caretakers
was also studied [41].
Catastrophic health expenditure
Catastrophic health expenditure has been reported to varying degree of threshold and denomi-
nators. Among the studies included in the review, two studies included household’s ‘capacity
to pay’ as denominator at 40% level threshold [24, 42] while Huffmann et al. used household
non-food expenditure [44]. Likewise, studies also included annual baseline income and total
household expenditure as denominator at 30% and 10% threshold respectively [31, 35]. Only
one study measured the intensity of catastrophic payment by assessing the mean positive over-
shoot which uses only those households that have experienced catastrophic health expenditure
in actual as the denominator [31].
Impoverishment
Out of 22 studies, only three studies dealt with impoverishment effect of out of pocket spend-
ing on health care for the NCDs of interest [24–26]. Impoverishment was expressed as percent-
age of household healthcare spending exceeding purchasing power parity represented in terms
of either relative poverty line USD 0.88 (for Bangladesh) [26] and absolute poverty line USD
1.25 per day per person [24]. Hamid et al. further represented medical impoverishment in
terms of poverty impact, poverty gap and normalized poverty gap [26]. While Engelgeu et al
expressed it in terms of odds of undergoing impoverishment for household with CVDs and
cancer as compared to household with communicable disease and used relative poverty line
estimates for different states and regions of India [25].
Coping strategy
Only13 studies dealt with the coping strategy adopted by individuals and households to meet
OOPP for NCDs related treatment. Studies reported either the percentage or risk of using
alternate financial measures like borrowing money, selling of assets, taking loans also denoted
as distress financing [30, 33].
Summary of the economic impact of NCDs in South Asia
Overall, this systematic review highlighted that major non-communicable diseases, like cardio-
vascular disease, cancer, diabetes and chronic respiratory diseases incurred economic impact
among households in South Asia, however, the extent and magnitude of the impact is still
inconclusive. Nonetheless, the studies in the review uniformly showed OOPP, catastrophic
health expenditure and impoverishment was higher among households with NCDs compared
to household without NCDs. Furthermore, the economic impact was visible at different
income levels. Borrowing and selling off assets were most commonly exhibited coping strategy
by South Asian household. These coping behaviors however differed inconsistently based on
place of residence either rural or urban.
Economic impact of cardiovascular diseases
In Table 2, studies showed that out of pocket health spending per person was high among
angina and CVDs affected household as compared to control and matched household respec-
tively [24, 28]. The regional proportion of households suffering from financial catastrophe for
CVD-related treatment ranged from 20% to 90% depending on the chosen income threshold
taken in the studies. The inter-country study among Nepal, Bangladesh, India, and Sri Lanka
Economic impact of NCDs in South Asia
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revealed that household in Bangladesh had the highest prevalence of catastrophic health
expenditure (as household’s capacity to pay at 40% cut off point) and impoverishment due to
Angina treatment (39.4% and 12.6% respectively). Among Nepalese household, a significant
proportion had to undergo borrowing or selling off assets (57.62%) to finance health expendi-
ture. However, much higher (84%) catastrophic spending was reported for Acute Coronary
Syndrome (ACS) treatment in India at the same threshold [42]. Studies reflected that the
financial hardship and catastrophic health expenditure led by CVDs treatment was visible in
both rich and poor households. More than a quarter (26.3%) of high-income Indian house-
holds had decreased income due to treatment for CVDs [44]. Likewise, the wealthiest house-
hold with heart disease from Nepal were 2.36 times more likely to undergo catastrophic health
expenditure as compared to the household without heart disease [31]. Moreover, borrowing,
contribution from friends, sell off assets to meet OOPP for CVDs treatment was found to be
concentrated in rural areas in India. Raj et. al showed that such coping strategies were promi-
nent even after completion of surgery for congenital heart surgery as more than half (52.1%) of
households in India reported borrowing money even after 6 months of discharge from con-
genital heart surgery to take care of the child and pay the loan made earlier for the treatment
[37]. (Table 2)
Economic impact of diabetes
Table 3 demonstrates the OOPP for diabetes in India and Pakistan, impoverishing effect in
Bangladesh and catastrophic health expenditure led by diabetes treatment in Nepal. Inpatient
diabetes care covered 17% of the household expenditure and income respectively in India [38,
45]. The cost of diabetic treatment varied significantly between private and public hospitals
(6602.13 USD vs. 1320.43 USD) in India within a year [45]. Khuwaja et al. reported slightly
higher direct cost for diabetes care in India as compared to Pakistan [46, 47]. Households with
diabetes posed more than twice the risk of spending more than 10% of total expenditure on
health than households without diabetes, and the mean positive overshoot was 10.2% [31].
Moreover, 5.25% of households fell into poverty due to payment for diabetes care in Bangla-
desh, and the poor household falls short of the poverty line by 1.1 cents [26]. Similar to financ-
ing for CVDs, in case of diabetes rural households continued to adopt distress financing as
compared to the urban household. Selling off assets and assistance from family or friends were
respectively 13 times and 21 times more common in diabetes affected households as compared
to households without diabetes [33]. (Table 3)
Economic impact of cancer
Table 4 shows the studies on the economic impact of cancer from India, Bangladesh, and Paki-
stan. The mean inpatient expenditure in cancer affected household was almost 5 times higher
than the matched control household in India (326.93 USD vs 66.42 USD) [29]. Whereas
another study in India reported very high cost of treatment alone of around USD 2543 [48]
and the cost of hospitalization was reported to be more than double in 8 years span [25]. Seven
out of ten households in Pakistan perceived breast cancer the imposed financial burden, and
the cost of treatment was unmanageable for breast cancer [41]. Studies reported significant
impoverishment induced by cancer treatment among households in Bangladesh and India [25,
26]. In Bangladesh, the impoverishing effect was much more pronounced for the most impov-
erished family as they further fall into poverty by 8% due to cancer treatment. This is the high-
est reported normalized poverty gap as compared to CVD and Diabetes by the same study.
Similar to other NCDs, households borrowed or sold the asset to finance for inpatient care as
compared to matched or control households [33]. (Table 4)
Economic impact of NCDs in South Asia
PLOS ONE | https://doi.org/10.1371/journal.pone.0205745 November 21, 2018 12 / 23
Economic impact of chronic respiratory diseases
Table 5 summarizes the studies conducted in India, Bangladesh, and Nepal on OOPP, cata-
strophic health expenditure, impoverishment and financial coping strategy adopted for treat-
ment of chronic respiratory diseases. The average out of pocket expenditures per visit for non-
domiciliary treatment of COPD was higher for urban households in Bangladesh than the rural
Table 3. Economic impact of diabetes.
Study
Design
Location Type of Outcome Outcome Specified as Assessment Type Point Estimate Author
Cross-
sectional
India OOPP Per hospital stay, private + public (1995–1996) Mean, $ 456.87 Engelgau
[25]
Per hospital stay, private + public 2004 Mean, $ 783.21
Per outpatient visit, private+public (1995–1996) Mean, $ 24.14
Per outpatient visit, private+public 2004 Mean, $ 41.77
OOPP Direct costs, per year (eg. Drugs, transport, consultations) Mean, $ (SD) 1103.30
(948.68)
Grover [46]
Indirect costs, per year (eg. Loss of income, days lost
because of illness for patient and caregivers)
Mean, $ (SD) 463.57 (1121.87)
Distress Financing Borrowed to meet OOPP on inpatient care (Rural/Urban) Percentage 46/26 Joe[27]
Contributions/assistance from friends/relatives to meet
OOP expenditure on inpatient care (Rural/Urban)
Percentage 27/21
Sale assets to meet OOPP on inpatient care (Rural/Urban) Percentage 9/2
Diabetes vs no diabetes: Borrowing to meet OOPP for
inpatient care
OR (95% CI) 1.01 (1.00,1.01)
Diabetes vs no diabetes: Sale of asset to meet OOPP for
inpatient care
OR (95% CI) 1.13 (1.11,1.15)
Diabetes vs no diabetes: Contribution/assistance from
friend to meet OOPP for inpatient care
OR (95% CI) 1.21 (1.20,1.22)
OOPP Mean OOP payment per hospitalization Mean, $ 418.49 Rao[38]
OPP share of total annual household expenditure Percentage 17
Income Family income in private hospital, per year Mean, $ 6602.13 Shobhana
[45]
Family income in public hospital, per year Mean, $ 1320.43
OOPP Income spent on DM, by inpatient care Percentage 17.5
Income spent on DM, by outpatient care Percentage 7.7
OOPP Average cost for each doctor visit Mean, $ (SD) 10.83 (6.799) Joshi [28]
Bangladesh Impoverishment Headcount impoverishment impact of OOPP Percentage 5.25 Hamid[58]
Average poverty gap Mean, $ 0.011
Normalized poverty gap Percentage 1
Pakistan OOPP Direct cost, per year Mean, $ 939.88 Khowaja
[47]
Indirect cost, per year Mean, $ 68.18
Nepal Catastrophic
Expenditure
Household spending >10% of total expenditure on health
care
Concentration Index
(95% CI)
0.099
(-0.304,0.107)
Saito[31]
Mean Positive Overshoot (Mean level/Additional
payments exceeding >10% threshold of THE)
Percentage 10.2
Diabetes vs no diabetes, among household from poorest
quintile
RR (95% CI) 2.37 (1.16, 4.83)
Diabetes vs no diabetes, among household from wealthiest
quintile
RR (95% CI) 0.45, 2.39)
DM: Diabetes Mellitus, SD: Standard Deviation, THE: Total Household Expenditure
https://doi.org/10.1371/journal.pone.0205745.t003
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ones (41.98 USD vs 4.38 USD) [49]. Almost 6% of the Bangladesh household fell into poverty
due to payment for asthma health care services, and the intensity of medical impoverishment
Table 4. Economic impact of cancer among household in South Asia.
Study
Design
Location Type of Outcome Outcome Specified as Assessment Type Point Estimate Author
Cross-
sectional
India OOPP Per hospital stay, private + public (1995–1996) Mean, $ 1044.28 Engelgau
[25]
Per hospital stay, private + public 2004 Mean, $ 2349.62
Per outpatient visit, private + public (1995–1996) Mean, $ 78.32
Per outpatient visit, private + public (1995–1996) Mean, $ 110.95
Catastrophic
Expenditure
Patients with Cancer versus CDs OR (95% CI) 2.7 (2.10, 3.10)
Impoverishment Patients with Cancer versus CDs OR (95% CI) 2.33 (1.86, 2.91)
Distress Financing Borrowed for financing inpatient care (Rural/Urban) Percentage 60/37 Joe[27]
Contributions/assistance from friends/relatives for financing
inpatient care(Rural/Urban)
Percentage 32/19
Sale assets for financing inpatient care(Rural/Urban) Percentage 14/10
Cancer vs no cancer: Borrowing for inpatient care OR (95% CI) 1.11 (1.10,1.12)
Cancer vs no cancer: Sale of asset for financing inpatient
care
OR (95% CI) 1.33 (1.32,1.34)
Cancer vs no cancer: Contribution from friends/relatives for
financing inpatient care
OR (95% CI) 1.29 (1.28,1.3)
OOPP Inpatient OOPE, per member in cancer affected household
(1year)
Mean, $ 326.93 (277.87,
375.99)
Mahal[29]
Inpatient OOPE, per member in matched control household
(1year)
Mean, $ 66.42 (43.21,
89.69)
Non-medical consumption expenditure, per member in
cancer affected household (15days)
Mean, $ (95%
CI)
18.09(18.53,
21.05)
Non-medical consumption expenditure, per member in
cancer affected household (15days)
Mean, $ (95%
CI)
19.76 (18.53,
21.05)
Coping Strategy Borrowing or selling assets to finance inpatient care in
cancer affected household
Percentage (95%
CI)
51.4(47.98, 54.82)
Borrowing or selling assets to finance inpatient care in
matched control household
Percentage (95%
CI)
15.77(13.28,
18.26)
OOPP Cost of investigation Mean, $ 1030.42 Nair[48]
Cost of treatment Mean, $ 2543.02
Indirect cost Mean, $ 1677.33
Opportunity cost Mean, $ 1118.20
Hardship Faced financial hardship Percentage 75
Coping Strategy Family saving Percentage 36.5
Borrowings Percentage 39.12
Sales of assets (land, cattle, ornament, etc.) Percentage 12.27
Medical reimbursement/ health insurance Percentage 6.22
Other assistance (Government/philanthropic) Percentage 5.89
Bangladesh Impoverishment Headcount impoverishment impact of OOPP Percentage 25 Hamid[58]
Average poverty gap Mean, $ 0.068
Normalized poverty gap Percentage 8
Pakistan Hardship Cost more than anticipated Percentage 70 Zaidi[41]
Perceived level of burden unmanageable Percentage 70
CDs: Communicable diseases
https://doi.org/10.1371/journal.pone.0205745.t004
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was increased by 2% for the poorest household. The risk of household undergoing catastrophic
health expenditure was higher in the poorest household as compared to wealthiest quintile, RR
2.09(1.39 at 95% CI) in Nepal. Around three-quarters of Bangladeshi household were at risk of
implementing one of the coping strategies like borrowing and selling off assets to finance for
Asthma treatment [30], and this risk was higher among urban households [49]. Among Indian
households the OOPP per inpatient treatment in private and public hospital for bronchial
asthma was increased tremendously between 1995 and 2004; 195.80 USD and 522.13 USD
respectively [25]. (Table 5)
Discussion
This systematic review summarizes 22 studies assessing the economic impact in terms of
OOPP, catastrophic health expenditure, impoverishment caused by management and treat-
ment of CVDs, diabetes, cancer, chronic respiratory diseases among households in South Asia
and their financial coping strategy. Households suffering from NCDs had higher out of pocket
expenditure, catastrophic health expenditures and were more likely to undergo impoverish-
ment compared to its counterparts without NCDs. The review also pointed out that the cur-
rent health services for these NCDs are unaffordable to already poverty-stricken population of
Table 5. Economic impact of chronic respiratory diseases among household in South Asia.
Study
Design
Location Type of Outcome Outcome Specified as Assessment Type Point Estimate Author
Cross-
sectional
India OOPP Per hospital stay, private + public (1995–1996) Mean, $ 195.80 Engelgau
[25]
OOPP Per hospital stay, private + public 2004 Mean, $ 522.13
Per outpatient visit, private + public (1995–1996) Mean, $ 20.88
Per outpatient visit, private + public 2004 Mean, $ 33.93
Bangladesh Impoverishment Headcount impoverishment impact of OOPP Percentage 5.89 Hamid[58]
Average poverty gap Mean, $ 0.018
Normalized poverty gap Percentage 2
Distress Financing Household with Asthma vs no Asthma RR (95% CI) 1.73 (1.35–2.22) Rahman
[30]
Financial Hardship Prevalence of economic consequences (Rural/Urban) Percentage 2.4/12.5 Uddin[60]
OOPP OOPE per visit for seeking outpatient treatment for
COPD Urban
Mean, $ 41.98
OOPE per visit for seeking outpatient treatment for
COPD Rural
Mean, $ 4.38
Coping Strategy Sold household assets (Rural/Urban) Percentage 0.3/1.1
Spent/reduced savings(Rural/Urban) Percentage 0.0/4.3
Reduced expenditure on food (Rural/Urban) Percentage 0.7/6.5
Borrowed money from relative/friend (Rural/Urban) Percentage 1/7.1
Nepal Catastrophic
Expenditure
Household spending >10% of total expenditure on health
care
Concentration Index
(95% CI)
−0.185 (−0.389
to 0.018)
Saito[31]
Mean Positive Overshoot (Mean level/Additional
payments exceeding >10% threshold of THE)
Percentage 12.3
Asthma vs no Asthma, among household from poorest
quintile
RR (95% CI) 2.09 (1.28, 3.42)
Asthma vs no Asthma, among household from wealthiest
quintile
RR (95% CI) 1.39 (0.40, 4.82)
THE: Total Household Expenditure
https://doi.org/10.1371/journal.pone.0205745.t005
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the region. The most common coping strategy adopted by South Asian household were bor-
rowing and selling off assets. Finally, it could be shown, that there is a lack of studies on the
economic impact of the specific type of cancer and COPD in the South Asian region.
Before discussing the major findings of this systematic review, it is important to discuss on
the methodological variations the studies have presented in measuring OOPP, catastrophic
health expenditure, impoverishment across South Asian countries. The methodological differ-
ences occurred in the measurement of out of pocket payment i.e. inclusion of direct cost, indi-
rect cost, non-medical cost and variance in recall period. Though a majority of the studies
were based on random samples, the cost associated with NCDs was self-reported in all cases.
These self-reported costs associated with NCDs even for random samples are likely to over-
report the expenses specially in lack of comparative group [16, 50]. The recall period in the
studies varied from a few days to 12 months. The longer recall period is subjected to misreport-
ing due to respondent inability to remember exact out of pocket expenditures while short
recall period does not capture the actual expenses and are likely to exaggerate or over report
the expenses [51, 52].
Currently, WHO uses the incidence of catastrophic health expenditures and the incidence
of impoverishment due to out-of-pocket health payments as indicators to monitor the level of
financial protection for Universal Health Coverage [53]. However, in this review majority of
the studies reported OOPP due to NCDs and only few studies reported the incidence of cata-
strophic health expenditure and even fewer (only three) studies reported incidence of impov-
erishment. Hence restressing the gap of availability of data regarding financial protection in
low and middle-income countries [53] including the South Asian region. Likewise, for mea-
surement of catastrophic health expenditure studies used different thresholds ranging from
10% and 40% spent as health expenditure of total household consumption expenditure or total
household non-food consumption expenditure while one study used “mean catastrophic posi-
tive overshoot” i.e. the degree by which the average out of pocket expenditure by households
that have experienced catastrophe has exceeded the given catastrophic threshold [51].Thus,
hindering the comparability between studies and diseases.
Similarly, approaches to assess impoverishment among the studies differed widely. Studies
either used absolute poverty line or locally derived poverty line while only one study assessed
poverty gap (i.e. households pushed further into poverty). Moreover, the OOPP, catastrophic
health expenditure and impoverishment are out-product of political and societal settings:
availability and access to health services, risk pooling and health financing mechanism and
poverty levels in each country. Hence results should be cautiously interpreted on these socio-
political paradigms [51, 54]. Thus, this systematic review highlights the need for standardized
definitions, thresholds for assessing OOPP and its impact, studies going beyond the measure-
ment of OOPP alone and measuring the incidence of catastrophic health expenditure and
impoverishment. Along with this, preparing tools that are not sensitive to political and societal
factors is must to make a cross-country and fair comparisons.
Additionally, most of the studies were cross-sectional, hence, failed to answer whether the
catastrophic and impoverishing effects observed, and coping strategy adopted occurred in a
unit of time or is the aggregation of such impacts over a period for a household. The duration
over which a household undergoes catastrophic or impoverishing effects may be more impor-
tant than the incidence of the results in the population itself [55] specially in case of NCDs
which require lifelong expenses for medication and care which was not reported in any of the
studies in the review. Moreover, majority of the studies in the review were of poor quality
mainly due to inadequately defined NCDs, lack of reference group/comparator and cross sec-
tion nature of the study (S2 Table). Out of pocket expense for NCDs in lack of reference
group or comparator gives very little information. Hence, these findings stress the need of
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robust research on NCDs and its economic impact with optimal methodological design along
with appropriate reference group and comparators group to facilitate the production of mean-
ingful and comparable national and regional estimates.
The trends of economic impact of NCDs and reasons can be presented and discussed, even
though the methodological differences are present. Firstly, the review reconfirmed that house-
holds suffering from NCDs had higher out of pocket expenditure, catastrophic health expendi-
tures and were more likely to undergo impoverishment compared to its counterparts which
concurs with similar literature review conducted in low and middle-income countries [56, 57].
A literature review on the financial burden on NCDs in resource constraint setting showed
that comorbidities associated with NCDs and the cost of medication occupied the largest pro-
portion in direct cost associated with treatment of NCDs [16, 58].
Secondly, the review also pointed out that the current health services for these NCDs are
unaffordable to already poverty-stricken population of the region. For instance, among the
studies in the review, the highest out of pocket direct cost 11,989 USD was reported for con-
genital heart surgery for 0 to 18 years children [37] in India where almost a quarter of the pop-
ulation live below 2 USD per day [5]. Similar disproportionate risk of catastrophic expenditure
among uninsured and poor household was also seen in case of chronic respiratory disease [26,
31] and CVDs [25, 35] in the review. Surprisingly, the consequential effect was also visible in
the high-income household [31, 44]. For instance, the households with heart disease from
wealthiest quintile in Nepal had slightly increased risk of catastrophic health expenditure than
the poorest household. This does not necessarily mean that the poorest household suffer less
from CVDs than richest household. This may also signify that poor household does not have
financial ability to seek care, so they avoid health service hence lesser expenditure altogether.
However, households or individuals not seeking health care for NCDs and its financial impli-
cations was overlooked and not discussed in any of the studies included in the review.
Thirdly, this systematic review also showed that borrowing and selling off assets as the most
common coping strategy adopted by households in the region for all major NCDs in this
review. A study done among African nations showed similar results for paying their inpatient
health costs [59]. However, the proportion of households adopting coping strategy varied
inconsistently between the rural or urban place of residence [27, 60]. On the one hand, this dif-
ference in coping behavior can be attributed to poor economic conditions where only well-
endowed households can pay for their health care services and people from the rural area must
find alternative measures to pay for their health [61]. Whereas the high percentage of urban
distress financing reiterates that coping behavior is strongly correlated with the availability of
social capital, valuable assets, possibility of getting a loan which is higher among affluent group
living in a urban household [59, 62]. High dependence on coping strategy at present will
reduce the ability of families to deal with unprecedented health shocks in the future and
increase debt in a poor household [57]. Furthermore, borrowing or incurring loan or contri-
butions from family and friends may also depend on the individual needing health care. The
healthcare need of female and elderly are not prioritized in the patriarchal society as such of
South Asia, hence reduced coping measures or not seeking health care at all [25]. This intersec-
tionality of gender and age group from the perspectives of health financing and coping strate-
gies among households has not been studied yet in low and middle-income countries [27].
Fourthly, one of the peculiar findings of the review is the lack of studies on the economic
impact of specific type of cancer and COPD in South Asian region. One the explanations for
this could be insufficient population-based cancer registry in the region to draw cancer-spe-
cific data [63]. It is commonsensical that disregarding different types, stages and trajectories of
cancer will lead to underreporting and underestimation of the financial burden caused by can-
cer [64, 65]. We identified 14 studies from India, 1 study from Nepal, 2 studies from Pakistan,
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2 studies from Bangladesh and 1 study from India, Bangladesh, Sri Lanka and Nepal com-
bined, which allows in-depth information from South Asian countries. The studies from Ban-
gladesh, Nepal and Sri Lanka were absent in previously conducted systematic review on global
impact and impoverishment of NCDs [18]. However, studies from Maldives and Bhutan were
still missing. This lack of evidence may be subjected to the fact that NCDs are emerging public
health problem in South Asia region where the health system is predominantly focused on
tackling the challenges caused by infectious disease [7, 66]. Similar lack of studies assessing the
economic impact of COPD could be because COPD is ignored as cough or smoker cough.
This leads to reduced number of individual seeking health service but potentially increase
costs due to ill-diagnosis or later diagnosis. As the epidemiological burden of COPD increases
in the region with aging population [67], it can be expected that household will undergo higher
out of pocket payment and its subsequent impact. Hence, future studies on the economic
impact of COPD in South Asia could provide us with crucial information.
Thus, given the lack of risk pooling mechanism, heavy dependence on paying out of pocket
for health financing followed by rapid privatization of health services in the region [8] and
preference of private health facilities over public facilities for quality of care and diagnostics in
case of NCDs [68]; it is very likely that seeking health care services for NCDs will push house-
holds to medical poverty and will create the intergenerational cycle of poverty and poor health
[8, 54]. If the current situation prevails it will also undermine the goal of attainment of Univer-
sal Health Coverage- appropriate care at affordable cost in the South Asian region. There has
been some initiatives from South Asian countries to bring forward population-based insurance
scheme [69–71], WHO Package of Essential Non-communicable program [72, 73]; however,
challenges remain. Recent evidences suggest that population covered under health insurance
program or national schemes is not an ultimate solution for financial protection [74, 75]. In
order to extend the financial protection national programs should be based on mechanisms
where the large share of health expenditure is prepaid through taxation or mandatory payment
system [74–76]. Likewise, pro-poor programs to eliminate financial barriers in uptake and
adherence to cost effective interventions needs to be prioritized [76]. This is however pro-
foundly absent in the South Asian region. Thus, in such a scenario the appropriate mix of pre-
ventive and promotive approaches to modify NCDs risk factors and reduce the
epidemiological burden hence reducing the cost associated with its treatment and manage-
ment in the long run could be beneficial.
One of the biggest strength of this systematic review was the comprehensive nature of
search strategy applied and use of Newcastle–Ottawa Quality Assessment Scale to assess the
quality of non-randomized studies including case-control and cohort studies [77]. This has
been previously tested in a systematic review done to evaluate the global impact of NCDs on
households and impoverishment with appropriate adaptation as per the objectives of this sys-
tematic review [18]. Another significant strength of the review is the conversion of local cur-
rency to US Dollars. The Purchasing Power Parity conversion rate is the number of units of a
country’s currency required to buy the same amounts of goods and services in the domestic
market as U.S. dollar would buy in the United States [78]. This conversion factor takes account
of the GDP of the country hence giving superior comparability than exchange rate. Moreover,
all USD converted to dollars in 2016 through consumer price index conversion takes inflation
rate in consideration hence inferences on out of pocket payment are comparable and reliable.
Most importantly, this systematic review provides the much-needed evidence assessing the
economic impact of NCDs, identifying the gaps in evidence gaps and understanding areas for
further research exclusively for South Asia.
The main limitation of our review is the use of only two databases, Medline and Embase for
searching articles though they cover a broad range of peer reviewed articles published from
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1946 to till date on biomedicine and health. Hence, this review may have missed related articles
from other databases. In order to minimize this limitation, we also conducted snowballing of
references to ensure no potentially relevant studies were left out. But we acknowledge that rele-
vant publications in local languages and ministerial surveys and reports regarding this issue
which could have been of vital importance has not been included in the review. Another major
limitation of this review occurred in the selection of cancer studies. We only included four
cancers with leading DALYs rates among men and women in South Asian region in the search
strategy for detail exploration. However, we widened out our inclusion criteria so that studies
assessing economic impact but failing to mention non-specific cancers/neoplasms was also
included in the review so that we do not miss out important information on cancer led eco-
nomic impact. Lastly, our review does not take in account of comorbidities associated with
NCDs which have found to play a significant role in increasing disease burden and cost of
treatment.
Conclusion
Our review suggests that the economic impact of CVDs, diabetes, cancer and chronic respira-
tory diseases among households in South Asia seems dire. Out of pocket payment, catastrophic
payment and impoverishment are significantly high in households with NCDs and affects
households in all income levels. Borrowing and selling off assets were most common coping
behavior exhibited by South Asian household and differed inconsistently with rural and urban
residence. However, the studies on economic impact associated with NCDs specially assessing
catastrophic health expenditure and impoverishment are inadequate in the region and the gap
of evidence for COPD and specific cancer is even higher. Thus, the review highlights the need
for robust research on economic impact of NCDs so that evidence-informed nationally tai-
lored prepayment mechanisms covering NCDs can be developed. The review also calls for
standardization of tools measuring out of pocket payment and associated catastrophic and
impoverishing effect in South Asia which will facilitate the production of meaningful and com-
parable national and regional estimates.
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